Ali Saffaei to Humans
This is a "connection" page, showing publications Ali Saffaei has written about Humans.
Connection Strength
0.045
-
COVID-19 and elective cosmetic procedures: Asymptomatic transmission in epidemic area and subsequent burdens. J Cosmet Dermatol. 2020 Aug; 19(8):1838-1839.
Score: 0.007
-
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents. 2020 04; 55(4):105945.
Score: 0.007
-
Multiple pigmented macules as a sequel of cosmetic lip micro-pigmentation: New clinical presentation of tattoo reactions. Niger Postgrad Med J. 2019 Oct-Dec; 26(4):244-246.
Score: 0.007
-
Filler migration and extensive lesions after lip augmentation: Adverse effects of polydimethylsiloxane filler. J Cosmet Dermatol. 2018 Dec; 17(6):996-999.
Score: 0.006
-
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19. Pulm Pharmacol Ther. 2021 10; 70:102069.
Score: 0.002
-
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947.
Score: 0.002
-
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
Score: 0.002
-
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
Score: 0.002
-
Extracorporeal membrane oxygenation and COVID-19: The causes of failure. J Card Surg. 2020 Oct; 35(10):2838-2843.
Score: 0.002
-
Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion. J Med Virol. 2021 01; 93(1):69-70.
Score: 0.002
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.002
-
Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106043.
Score: 0.002
-
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):10-12.
Score: 0.002
-
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341.
Score: 0.002